Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach - Fig 1

Plasma HIV-1 RNA Dynamics in Antiretroviral-Naive Subjects Receiving either Triple-Nucleoside

September 2016

(See the editorial commentary by Markowitz and Perelson, on pages 1087–8.) Objective. We sought to c...

Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings

Sasisopin Kiertiburanakul
David Boettiger
Oon Tek Ng
Nguyen Van Kinh
Tuti Parwati Merati
Anchalee Avihingsanon
Wing-Wai Wong
Man Po Lee
Romanee Chaiwarith
Adeeba Kamarulzaman
Pacharee Kantipong
Fujie Zhang
Jun Yong Choi
Nagalingeswaran Kumarasamy
Rossana Ditangco
Do Duy Cuong
Shinichi Oka
Benedict Lim Heng Sim
Winai Ratanasuwan
Penh Sun Ly
Evy Yunihastuti
Sanjay Pujari
Jeremy L. Ross
Matthew Law
Somnuek Sungkanuparph
on behalf of the TREAT Asia HIV Observational Databases (TAHOD)

May 2017

Abstract Background Abacavir and rilpivirine are alternative antiretroviral drugs for treatment-naïv...

Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements

Pablo Barreiro
Sonia Rodriguez-novoa
Judit Morello
Carmen De Mendoza
Vincent Soriano

March 2015

Background: The choice of antiretroviral drugs has evolved over the last decade. Recognition of tren...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli, C
Basso, M
Andreis, S
Scaggiante, R
Cruciani, M
Ferretto, R
Panese, S
Manfrin, V
Francisci, D
Schiaroli, E
Maffongelli, G
Sarmati, L
Andreoni, M
Baldelli, F
Palu, G
Parisi, Sg

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach.

Carlo Mengoli
Monica Basso
Samantha Andreis
Renzo Scaggiante
Mario Cruciani
Roberto Ferretto
Sandro Panese
Vinicio Manfrin
Daniela Francisci
Elisabetta Schiaroli
Gaetano Maffongelli
Loredana Sarmati
Massimo Andreoni
Franco Baldelli
Giorgio Palu'
Saverio Giuseppe Parisi

January 2019

Background and aimsWe investigated the conditioning roles of viral tropism and other variables on pl...

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

Hoetelmans, R. M.
Reijers, M. H.
Weverling, G. J.
ten Kate, R. W.
Wit, F. W.
Mulder, J. W.
Weigel, H. M.
Frissen, P. H.
Roos, M.
Jurriaans, S.
Schuitemaker, H.
de Wolf, F.
Beijnen, J. H.
Lange, J. M.

January 1998

OBJECTIVE: To investigate the relationship between exposure to antiretroviral drugs and the initial ...

Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naive HIV-1 infected patients

Roshammar, Daniel
Simonsson, Ulrika S. H.
Ekvall, Hakan
Flamholc, Leo
Ormaasen, Vidar
Vesterbacka, Jan
Wallmark, Eva
Ashton, Michael
Gisslen, Magnus

January 2011

The objective of this analysis was to compare three methods of handling HIV-RNA data below the limit...

Importance table generated using lrna6 as outcome variable according to the increase of node purity induced by each predictive variable.

Carlo Mengoli (6104639)
Monica Basso (6104621)
Samantha Andreis (6104624)
Renzo Scaggiante (6104627)
Mario Cruciani (4843038)
Roberto Ferretto (6444242)
Sandro Panese (6444245)
Vinicio Manfrin (6444248)
Daniela Francisci (167519)
Elisabetta Schiaroli (167530)
Gaetano Maffongelli (4026314)
Loredana Sarmati (431865)
Massimo Andreoni (103649)
Franco Baldelli (167545)
Giorgio Palu' (6444251)
Saverio Giuseppe Parisi (4026326)

March 2019

Method: random forest. (a) FPR 10-transformed plasma HIV RNA at T0; lcd4_0: log10-transformed CD4+ c...

Antiretroviral Drugs Detected in Plasma Samples Collected at the Last Study Visit.

Iris Chen (490285)
William Clarke (433138)
San-San Ou (737153)
Mark A. Marzinke (734979)
Autumn Breaud (804164)
Lynda M. Emel (804165)
Jing Wang (4865)
James P. Hughes (205509)
Paul Richardson (48962)
Danielle F. Haley (804166)
Jonathan Lucas (804167)
Anne Rompalo (804168)
Jessica E. Justman (502985)
Sally L. Hodder (502986)
Susan H. Eshleman (111762)

October 2015

<p>The table shows the patterns of antiretroviral (ARV) drugs detected in plasma samples from HIV-un...

Study cohort characteristics and slope of HIV-1 Total DNA trendlines.

Yu Ming Paul Lam (330981)
Kristin L. McBride (330982)
Janaki Amin (157661)
Damien V. Cordery (330984)
Anthony D. Kelleher (242189)
David A. Cooper (198765)
Kersten K. Koelsch (330985)

February 2013

<p>Note: All patients had HIV-1 RNA levels of <50 copies per mL of plasma for the duration of the st...

Plasma HIV-1 RNA Dynamics in Antiretroviral-Naive Subjects Receiving either Triple-Nucleoside

September 2016

(See the editorial commentary by Markowitz and Perelson, on pages 1087–8.) Objective. We sought to c...

Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings

Sasisopin Kiertiburanakul
David Boettiger
Oon Tek Ng
Nguyen Van Kinh
Tuti Parwati Merati
Anchalee Avihingsanon
Wing-Wai Wong
Man Po Lee
Romanee Chaiwarith
Adeeba Kamarulzaman
Pacharee Kantipong
Fujie Zhang
Jun Yong Choi
Nagalingeswaran Kumarasamy
Rossana Ditangco
Do Duy Cuong
Shinichi Oka
Benedict Lim Heng Sim
Winai Ratanasuwan
Penh Sun Ly
Evy Yunihastuti
Sanjay Pujari
Jeremy L. Ross
Matthew Law
Somnuek Sungkanuparph
on behalf of the TREAT Asia HIV Observational Databases (TAHOD)

May 2017

Abstract Background Abacavir and rilpivirine are alternative antiretroviral drugs for treatment-naïv...

Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements

Pablo Barreiro
Sonia Rodriguez-novoa
Judit Morello
Carmen De Mendoza
Vincent Soriano

March 2015

Background: The choice of antiretroviral drugs has evolved over the last decade. Recognition of tren...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli, C
Basso, M
Andreis, S
Scaggiante, R
Cruciani, M
Ferretto, R
Panese, S
Manfrin, V
Francisci, D
Schiaroli, E
Maffongelli, G
Sarmati, L
Andreoni, M
Baldelli, F
Palu, G
Parisi, Sg

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach

Mengoli C.
Basso M.
Andreis S.
Scaggiante R.
Cruciani M.
Ferretto R.
Panese S.
Manfrin V.
Francisci D.
Schiaroli E.
Maffongelli G.
Sarmati L.
Andreoni M.
Baldelli F.
Palu G.
Parisi S. G.

March 2019

We investigated the conditioning roles of viral tropism and other variables on plasma HIV RNA levels...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach.

Carlo Mengoli
Monica Basso
Samantha Andreis
Renzo Scaggiante
Mario Cruciani
Roberto Ferretto
Sandro Panese
Vinicio Manfrin
Daniela Francisci
Elisabetta Schiaroli
Gaetano Maffongelli
Loredana Sarmati
Massimo Andreoni
Franco Baldelli
Giorgio Palu'
Saverio Giuseppe Parisi

January 2019

Background and aimsWe investigated the conditioning roles of viral tropism and other variables on pl...

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

Hoetelmans, R. M.
Reijers, M. H.
Weverling, G. J.
ten Kate, R. W.
Wit, F. W.
Mulder, J. W.
Weigel, H. M.
Frissen, P. H.
Roos, M.
Jurriaans, S.
Schuitemaker, H.
de Wolf, F.
Beijnen, J. H.
Lange, J. M.

January 1998

OBJECTIVE: To investigate the relationship between exposure to antiretroviral drugs and the initial ...

Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naive HIV-1 infected patients

Roshammar, Daniel
Simonsson, Ulrika S. H.
Ekvall, Hakan
Flamholc, Leo
Ormaasen, Vidar
Vesterbacka, Jan
Wallmark, Eva
Ashton, Michael
Gisslen, Magnus

January 2011

The objective of this analysis was to compare three methods of handling HIV-RNA data below the limit...

Importance table generated using lrna6 as outcome variable according to the increase of node purity induced by each predictive variable.

Carlo Mengoli (6104639)
Monica Basso (6104621)
Samantha Andreis (6104624)
Renzo Scaggiante (6104627)
Mario Cruciani (4843038)
Roberto Ferretto (6444242)
Sandro Panese (6444245)
Vinicio Manfrin (6444248)
Daniela Francisci (167519)
Elisabetta Schiaroli (167530)
Gaetano Maffongelli (4026314)
Loredana Sarmati (431865)
Massimo Andreoni (103649)
Franco Baldelli (167545)
Giorgio Palu' (6444251)
Saverio Giuseppe Parisi (4026326)

March 2019

Method: random forest. (a) FPR 10-transformed plasma HIV RNA at T0; lcd4_0: log10-transformed CD4+ c...

Antiretroviral Drugs Detected in Plasma Samples Collected at the Last Study Visit.

Iris Chen (490285)
William Clarke (433138)
San-San Ou (737153)
Mark A. Marzinke (734979)
Autumn Breaud (804164)
Lynda M. Emel (804165)
Jing Wang (4865)
James P. Hughes (205509)
Paul Richardson (48962)
Danielle F. Haley (804166)
Jonathan Lucas (804167)
Anne Rompalo (804168)
Jessica E. Justman (502985)
Sally L. Hodder (502986)
Susan H. Eshleman (111762)

October 2015

<p>The table shows the patterns of antiretroviral (ARV) drugs detected in plasma samples from HIV-un...

Study cohort characteristics and slope of HIV-1 Total DNA trendlines.

Yu Ming Paul Lam (330981)
Kristin L. McBride (330982)
Janaki Amin (157661)
Damien V. Cordery (330984)
Anthony D. Kelleher (242189)
David A. Cooper (198765)
Kersten K. Koelsch (330985)

February 2013

<p>Note: All patients had HIV-1 RNA levels of <50 copies per mL of plasma for the duration of the st...

Plasma HIV-1 RNA Dynamics in Antiretroviral-Naive Subjects Receiving either Triple-Nucleoside

September 2016

(See the editorial commentary by Markowitz and Perelson, on pages 1087–8.) Objective. We sought to c...

Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings

Sasisopin Kiertiburanakul
David Boettiger
Oon Tek Ng
Nguyen Van Kinh
Tuti Parwati Merati
Anchalee Avihingsanon
Wing-Wai Wong
Man Po Lee
Romanee Chaiwarith
Adeeba Kamarulzaman
Pacharee Kantipong
Fujie Zhang
Jun Yong Choi
Nagalingeswaran Kumarasamy
Rossana Ditangco
Do Duy Cuong
Shinichi Oka
Benedict Lim Heng Sim
Winai Ratanasuwan
Penh Sun Ly
Evy Yunihastuti
Sanjay Pujari
Jeremy L. Ross
Matthew Law
Somnuek Sungkanuparph
on behalf of the TREAT Asia HIV Observational Databases (TAHOD)

May 2017

Abstract Background Abacavir and rilpivirine are alternative antiretroviral drugs for treatment-naïv...

Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements

Pablo Barreiro
Sonia Rodriguez-novoa
Judit Morello
Carmen De Mendoza
Vincent Soriano

March 2015

Background: The choice of antiretroviral drugs has evolved over the last decade. Recognition of tren...

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach - Fig 1

Abstract

Extracted data

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach - Fig 1

Abstract

Extracted data

Related items

Related items